Tg(Thy1-APPSwe,Prnp-PSEN2*N141I)152HLaoz
Transgene Detail
|
Symbol: |
Tg(Thy1-APPSwe,Prnp-PSEN2*N141I)152HLaoz |
Name: |
transgene insertion 152H, Laurence Ozmen |
MGI ID: |
MGI:4412048 |
Synonyms: |
B6.152H, PS2APP |
Transgene: |
Tg(Thy1-APPSwe,Prnp-PSEN2*N141I)152HLaoz Location: unknown
|
Alliance: |
Tg(Thy1-APPSwe,Prnp-PSEN2*N141I)152HLaoz page
|
|
|
Transgene Type: |
|
Transgenic (Humanized sequence, Inserted expressed sequence) |
Mutation: |
|
Insertion
|
|
|
Tg(Thy1-APPSwe,Prnp-PSEN2*N141I)152HLaoz expresses
2 genes
Transgene expresses:
Organism |
Expressed Gene |
Homolog in Mouse |
Note |
human |
APP (351) |
|
The gene encodes for the Swedish mutations. |
human |
PSEN2 (5664) |
|
|
|
|
|
Mutation details: A construct containing a Thy1 promoter driving expression of the human APP with the Swedish familial Alzheimer disease mutations (K670N, M671L) was co-injected with a construct containing the Prnp promoter driving the expression of human PSEN2 with the familial Alzheimer disease mutation N141I. Line 152H was used in subsequent experiments.
(J:88193, J:154969)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 1 strain available
Cell Lines: 0 lines available
|
|
Original: |
J:154969 Ozmen L, et al., Expression of transgenic APP mRNA is the key determinant for beta-amyloid deposition in PS2APP transgenic mice. Neurodegener Dis. 2009;6(1-2):29-36 |
All: |
29 reference(s) |
|